Description

Dalstep 10: Clinical Dalfampridine 10mg Guide

Dalstep 10 is a prescription-only medicine (POM) manufactured by Sun Pharma Laboratories Limited. Dalfampridine, the active substance in each tablet, is present at a strength of 10mg. In the UK, this medicine is licensed to help adults with Multiple Sclerosis (MS) improve their walking ability. This international brand is bioequivalent to the UK reference brand Fampyra, meaning it delivers the same active drug at identical concentrations to the body. UK patients prescribed this medicine must access it through a regulated pharmacy supply with a valid prescription.

Composition

Active Ingredient:

Dalfampridine (as extended-release) 10 mg per tablet

Dosage Form:

Extended-release oral tablet

Manufacturer

Sun Pharmaceutical Industries Limited.

Expiry

Expiry may vary by batch; always check the pack for the exact Dalstep 10 expiry date.

What is Dalstep 10?

Dalstep 10 is a formulation containing Dalfampridine (10mg). It acts as a potassium channel blocker, enhancing nerve conduction in damaged pathways. For those who need this type of treatment, it offers a cost-effective option.

Scientific Consistency: Dalstep 10 vs Fampyra

Characteristic	Dalstep 10	Fampyra
Active Ingredient (Salt)	Dalfampridine	Dalfampridine
Strength	10mg	10mg
Mechanism of Action	Potassium channel blocker	Potassium channel blocker
Chemical Class	Aminopyridine	Aminopyridine
Bioequivalence	Yes	Reference Product
Therapeutic Effect	Improves walking speed in MS	Improves walking speed in MS

Mechanism of Action

Dalfampridine blocks microscopic potassium channels in damaged, demyelinated (lacking the protective nerve sheath) nerve fibres.

Stopping potassium leakage strengthens the electrical signal travelling down the axon (nerve fibre).

This action restores or improves neurological transmission in the central nervous system. Consequently, the signal reaches the muscles more effectively, thereby improving walking speed.

Clinical Uses

• Helping to improve walking ability in adults with MS.
• Enhancing walking speed in individuals demonstrating a clinical response within two weeks of initiation.

Safety Information

Like all prescription medicines, Dalfampridine can cause side effects, though not everyone experiences them.

Side Effect Category	Side Effects
Common side effects	Urinary tract infections, insomnia (difficulty sleeping), dizziness, headache, nausea, and back pain
Serious side effects	Seizures (fits), severe allergic reactions (anaphylaxis), and new or worsening balance disorders

Any adverse reactions can be reported through the MHRA’s Yellow Card Scheme.

Safety Advice

Liver

No dosage adjustment is needed for patients with hepatic impairment (liver damage).

Kidney

For patients with moderate-to-severe renal impairment, this medicine must not be used.

Alcohol

Alcohol can increase the risk of seizures. It should therefore be avoided while taking this medicine.

Driving

Dizziness is a possible side effect of Dalfampridine, and this could affect your ability to drive or use machinery safely.

Pregnancy

It is preferable to avoid using this medicine during pregnancy.

Breastfeeding

Research has yet to confirm whether traces of this medicine can pass into breast milk.

Accessing Treatment Responsibly

You can access Dalstep 10 responsibly through authorised online pharmacies following prescription verification. All orders undergo a strict clinical assessment before supply.

Frequently Asked Questions

Q: What is Dalstep 10mg used for?

A: Dalstep 10mg is available on prescription and is used to improve walking ability in adults with Multiple Sclerosis. It helps patients walk faster and more consistently.

Q: What are the benefits of dalfampridine?

A: Dalfampridine increases walking speed and improves lower limb mobility. For people living with Multiple Sclerosis, this treatment can support better coordination and physical function in daily life.

Q: How long does it take dalfampridine to work?

A: Most patients show a clinical improvement within two weeks of starting treatment. A healthcare professional will assess your walking progress after this initial period.

Q: Does dalfampridine affect kidney function?

A: The kidneys excrete this medicine. It does not damage healthy kidneys, but patients with moderate to severe renal impairment must not take it.

Conclusion

Dalstep 10 (Dalfampridine) 10mg provides a regulated, clinically proven mechanism to improve mobility in MS patients. Always consult a qualified UK healthcare professional before starting or changing your treatment.

References

• Electronic Medicines Compendium (eMC), Fampyra 10mg prolonged-release tablets.
• MHRA Yellow Card Scheme reporting guidelines (2026).

Medical Disclaimer

Although shared here to inform readers, none of this content can take the place of guidance from a qualified medical professional regarding diagnosis or treatment.